{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:51:08Z","timestamp":1788691868458,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.urolonc.2021.01.031","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T13:06:37Z","timestamp":1616072797000},"page":"436.e1-436.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma"],"prefix":"10.1016","volume":"39","author":[{"given":"Marco","family":"Paciotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David-Dan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Modonutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorine","family":"Haeuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Lipsitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Mossanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Kibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Lughezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quoc-Dien","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.urolonc.2021.01.031_bib0001","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","article-title":"Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria","year":"2017","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.01.031_bib0002","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.urolonc.2021.01.031_bib0003","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupr\u00eat","year":"2018","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.01.031_bib0004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cncr.28754","article-title":"Cytotoxic and DNA-targeted therapy in urothelial cancer: have we squeezed the lemon enough?","volume":"121","author":"Balar","year":"2015","journal-title":"Cancer"},{"issue":"7492","key":"10.1016\/j.urolonc.2021.01.031_bib0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.urolonc.2021.01.031_bib0006","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.eururo.2014.05.034","article-title":"Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium","volume":"66","author":"Heng","year":"2014","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.01.031_bib0007","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","article-title":"Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia","volume":"5","author":"Glehen","year":"2004","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.01.031_bib0008","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival Effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.01.031_bib0009","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2013.11.012","article-title":"Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study","volume":"65","author":"Culp","year":"2014","journal-title":"Eur Urol"},{"issue":"29","key":"10.1016\/j.urolonc.2021.01.031_bib0010","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1200\/JCO.2016.66.7352","article-title":"Efficacy of high-intensity local treatment for metastatic urothelial carcinoma of the bladder: a propensity score\u2013weighted analysis from the national cancer data base","volume":"34","author":"Seisen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.01.031_bib0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eururo.2016.04.031","article-title":"The impact of local treatment on overall survival in patients with metastatic prostate cancer on diagnosis: a national cancer data base analysis","volume":"72","author":"L\u00f6ppenberg","year":"2017","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.01.031_bib0012","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/01.ju.0000110610.61545.ae","article-title":"Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis","volume":"171","author":"Flanigan","year":"2004","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.urolonc.2021.01.031_bib0013","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41585-019-0217-z","article-title":"Combining options in metastatic prostate cancer","volume":"16","author":"Kopp","year":"2019","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.01.031_bib0014","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.euo.2019.06.014","article-title":"Efficacy of surgery in the primary tumor site for metastatic urothelial cancer: analysis of an international, multicenter, multidisciplinary database","volume":"3","author":"Moschini","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.01.031_bib0015","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2017.09.030","article-title":"The role of surgery in metastatic bladder cancer: a systematic review","volume":"73","author":"Abufaraj","year":"2018","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.01.031_bib0016","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.euf.2016.12.003","article-title":"Impact of baseline characteristics on the survival benefit of high-intensity local treatment in metastatic urothelial carcinoma of the bladder","volume":"4","author":"Vetterlein","year":"2018","journal-title":"Eur Urol Focus"},{"issue":"6","key":"10.1016\/j.urolonc.2021.01.031_bib0017","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1200\/JCO.2017.76.1759","article-title":"Radical treatment of the primary tumor in metastatic bladder cancer: potentially dangerous findings from observational data","volume":"36","author":"Booth","year":"2018","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.01.031_bib0018","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.1016\/j.clgc.2019.03.003","article-title":"Survival effect of nephroureterectomy in metastatic upper urinary tract urothelial carcinoma","volume":"17","author":"Nazzani","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2021.01.031_bib0019","first-page":"269","article-title":"Risk factors and reasons for reoperation after radical cystectomy","volume":"38","author":"Reese","year":"2020","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"4","key":"10.1016\/j.urolonc.2021.01.031_bib0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.urolonc.2017.08.008","article-title":"Secondary data sources for health services research in urologic oncology","volume":"36","author":"Cole","year":"2018","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.01.031_bib0021","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The national cancer data base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.01.031_bib0022","doi-asserted-by":"crossref","DOI":"10.1111\/bju.13966","article-title":"Immortal-time bias: a crucial yet overlooked confounder in urological research","volume":"120","author":"Fletcher","year":"2017","journal-title":"BJU Int"},{"issue":"25","key":"10.1016\/j.urolonc.2021.01.031_bib0023","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.urolonc.2021.01.031_bib0024","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/oxfordjournals.aje.a113284","article-title":"A review of goodness of fit statistics for use in the development of logistic regression models1","volume":"115","author":"Lemeshow","year":"1982","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.urolonc.2021.01.031_bib0025","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.urolonc.2021.01.031_bib0026","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmpb.2003.10.004","article-title":"Adjusted survival curves with inverse probability weights","volume":"75","author":"Cole","year":"2004","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.urolonc.2021.01.031_bib0027","article-title":"Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis","author":"Tully","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2021.01.031_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","author":"Birtle","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.urolonc.2021.01.031_bib0029","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.eururo.2016.11.012","article-title":"Efficacy of systemic chemotherapy plus radical nephroureterectomy for metastatic upper tract urothelial carcinoma","volume":"71","author":"Seisen","year":"2017","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.01.031_bib0030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/cncr.32562","article-title":"The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years","volume":"126","author":"Fletcher","year":"2020","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.urolonc.2021.01.031_bib0031","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/jcm8081190","article-title":"Lymphadenectomy for upper tract urothelial carcinoma: a systematic review","volume":"8","author":"Duquesne","year":"2019","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.urolonc.2021.01.031_bib0032","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00345-017-2026-4","article-title":"Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy","volume":"35","author":"Moschini","year":"2017","journal-title":"World J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921000570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921000570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:20:37Z","timestamp":1761042037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921000570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1078143921000570"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.01.031","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}